Chart Industries, Inc. (NYSE: GTLS) today reported results for the second quarter 2025 ended June 30, 2025. Second quarter 2025 highlights compared to second quarter 2024: Orders of $1.50 billion, an ...

Despite recent share price underperformance, I maintain a bullish outlook and consider Kinder Morgan a quality 'buy' ...

In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...

Chart Industries, Inc. (NYSE: GTLS) today reported results for the second quarter 2025 ended June 30, 2025. Second quarter 2025 highlights compared to second ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

In April 2025, Radiopharm dosed the first patient in the U.S. Phase 2b imaging study of 18F-RAD101. The multicenter, open-label, single arm Phase 2b clinical trial is evaluating the diagnostic ...

Roche Holding AG's H2 2025 earnings show solid growth in pharma revenues but highlight pipeline struggles and U.S. pricing pressures. Click for my RHHBY update.

Wall Street is split on two of the biggest names in entertainment, Disney stock ($DIS) and Netflix stock ($NFLX), as both ...

According to Glassnode, bitcoin dip buyers are adding exposure around the $117,000 level, with 73,000 BTC now held at this ...

Liberty Energy Inc. LBRT reported a second-quarter 2025 adjusted net income of 12 cents per share, missing the Zacks ...

Mustang Bio Inc. company and executive profile by Barron's. View the latest MBIO company infomation and executive bios.

Energy Transfer is a solid stock to buy now and hold for the long term. ExxonMobil built its business to thrive in all market ...